FIELD TRIP HEALTH LTD (FTRP) Fundamental Analysis & Valuation

NASDAQ:FTRP • CA31656R1029

Current stock price

0.8421 USD
+0.01 (+1.07%)
At close:
0.8698 USD
+0.03 (+3.29%)
After Hours:

This FTRP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FTRP Profitability Analysis

1.1 Basic Checks

  • In the past year FTRP has reported negative net income.
FTRP Yearly Net Income VS EBIT VS OCF VS FCFFTRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 -10M -20M -30M -40M -50M

1.2 Ratios

Industry RankSector Rank
ROA -53.55%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FTRP Yearly ROA, ROE, ROICFTRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

Industry RankSector Rank
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FTRP Yearly Profit, Operating, Gross MarginsFTRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. FTRP Health Analysis

2.1 Basic Checks

  • FTRP does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, FTRP has more shares outstanding
  • The debt/assets ratio for FTRP is higher compared to a year ago.
FTRP Yearly Shares OutstandingFTRP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
FTRP Yearly Total Debt VS Total AssetsFTRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -0.77, we must say that FTRP is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.40 indicates that FTRP is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z -0.77
ROIC/WACCN/A
WACC8.25%
FTRP Yearly LT Debt VS Equity VS FCFFTRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 8.20 indicates that FTRP has no problem at all paying its short term obligations.
  • FTRP has a Quick Ratio of 8.20. This indicates that FTRP is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 8.2
Quick Ratio 8.2
FTRP Yearly Current Assets VS Current LiabilitesFTRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. FTRP Growth Analysis

3.1 Past

  • The earnings per share for FTRP have decreased strongly by -15.25% in the last year.
  • Looking at the last year, FTRP shows a very strong growth in Revenue. The Revenue has grown by 471.78%.
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.89%
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%225.3%

3.2 Future

  • FTRP is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.94% yearly.
  • FTRP is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 99.77% yearly.
EPS Next Y-20.59%
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%
EPS Next 5Y0.94%
Revenue Next Year267.08%
Revenue Next 2Y77.85%
Revenue Next 3Y91.55%
Revenue Next 5Y99.77%

3.3 Evolution

FTRP Yearly Revenue VS EstimatesFTRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 20M 40M 60M
FTRP Yearly EPS VS EstimatesFTRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. FTRP Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for FTRP. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FTRP. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FTRP Price Earnings VS Forward Price EarningsFTRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.58
FTRP Per share dataFTRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • A cheap valuation may be justified as FTRP's earnings are expected to decrease with -2.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FTRP Dividend Analysis

5.1 Amount

  • FTRP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

FTRP Fundamentals: All Metrics, Ratios and Statistics

FIELD TRIP HEALTH LTD

NASDAQ:FTRP (8/16/2022, 8:00:00 PM)

After market: 0.8698 +0.03 (+3.29%)

0.8421

+0.01 (+1.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)08-15
Earnings (Next)11-14
Inst Owners0.03%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.97M
Revenue(TTM)4.86M
Net Income(TTM)-54.69M
Analysts82.22
Price Target50.54 (5901.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.03
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB N/A
EV/EBITDA -0.58
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.9
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.06
BVpS0.89
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -53.55%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -1091.39%
PM (TTM) -1125.3%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.2
Quick Ratio 8.2
Altman-Z -0.77
F-Score2
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.89%
EPS Next Y-20.59%
EPS Next 2Y-10.54%
EPS Next 3Y-2.39%
EPS Next 5Y0.94%
Revenue 1Y (TTM)471.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%225.3%
Revenue Next Year267.08%
Revenue Next 2Y77.85%
Revenue Next 3Y91.55%
Revenue Next 5Y99.77%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

FIELD TRIP HEALTH LTD / FTRP Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for FIELD TRIP HEALTH LTD?

ChartMill assigns a fundamental rating of 3 / 10 to FTRP.


Can you provide the valuation status for FIELD TRIP HEALTH LTD?

ChartMill assigns a valuation rating of 3 / 10 to FIELD TRIP HEALTH LTD (FTRP). This can be considered as Overvalued.


How profitable is FIELD TRIP HEALTH LTD (FTRP) stock?

FIELD TRIP HEALTH LTD (FTRP) has a profitability rating of 0 / 10.


Can you provide the financial health for FTRP stock?

The financial health rating of FIELD TRIP HEALTH LTD (FTRP) is 4 / 10.


What is the expected EPS growth for FIELD TRIP HEALTH LTD (FTRP) stock?

The Earnings per Share (EPS) of FIELD TRIP HEALTH LTD (FTRP) is expected to decline by -20.59% in the next year.